or Try an Advanced Search...

    Drug Resistant Bacterial Infections Stocks List

    Symbol Grade Name % Change
    SPRO F Spero Therapeutics, Inc. -1.25
    APTO F Aptose Biosciences, Inc. 0.70
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Bacterial Infections Biopharmaceutical Acute Myeloid Leukemia Antimicrobial Resistance Bemcentinib Cancer Cancer Therapies Clinical Medicine Drugs Evolutionary Biology Gemcitabine Hematologic Malignancies Immunotherapy Medicine Multi Drug Resistant Bacterial Infections Oncology Pancreatic Cancer Phosphoinositide 3 Kinase Inhibitor Preclinical Stage Product Preclinical Stage Products

    Related ETFs - A few ETFs which own one or more of the above listed Drug Resistant Bacterial Infections stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.01
    VTI A Vanguard Total Stock Market ETF 0.0
    VXF B Vanguard Extended Market ETF 0.0
    View all Drug Resistant Bacterial Infections ETFs...
    Compare ETFs
    Compare IWC to VTI Compare IWC to VXF Compare VTI to VXF

        Drug Resistant Bacterial Infections Stocks Recent News

        Date Stock Title
        Nov 20 SPRO Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 19 SPRO FATE Presents Encourgaing Data From Lupus Study, Stock Gains
        Nov 19 SPRO CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
        Nov 18 SPRO TenNor’s Phase III antibiotic trial meets all primary endpoints
        Nov 18 SPRO CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
        Nov 17 SPRO Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 14 SPRO Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates
        Nov 14 SPRO Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
        Related Industries: Biotechnology
        Related Stock Lists: Bacterial Infections Biopharmaceutical Acute Myeloid Leukemia Antimicrobial Resistance Bemcentinib Cancer Cancer Therapies Clinical Medicine Drugs Evolutionary Biology Gemcitabine Hematologic Malignancies Immunotherapy Medicine Multi Drug Resistant Bacterial Infections Oncology Pancreatic Cancer Phosphoinositide 3 Kinase Inhibitor Preclinical Stage Product Preclinical Stage Products
        Drug Resistant Bacterial Infections

        Drug Resistant Bacterial Infections are infections caused by bacteria that have become resistant to antibiotics. These infections can be difficult to treat and can lead to serious health complications. Antibiotic resistance occurs when bacteria change in a way that reduces or eliminates the effectiveness of drugs, chemicals, or other agents designed to cure or prevent infections.

        Browse All Tags